Emmis Acquisition (EMIS) vs Satellos Bioscience (MSLE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Emmis Acquisition is the larger company by market cap ($162.0 million vs $161.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EMIS | MSLE |
|---|---|---|
| Share price | $10.27 | $7.63 |
| Market cap | $162.02M | $161.88M |
| 1-day change | 0.00% | +1.19% |
| YTD return | +3.22% | +29.76% |
| 1-year return | — | +5.44% |
| 5-year return | — | -48.93% |
| EPS (TTM) | — | $-1.95 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.27 | $13.40 |
| 52-week low | $9.90 | $5.30 |
| Distance from 52-week high | 0.00% | -43.04% |
| Average volume | 13.89K | 51.35K |
| Shares outstanding | 11.94M | 21.22M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
EMIS vs MSLE FAQ
Which is bigger, Emmis Acquisition or Satellos Bioscience?
Emmis Acquisition (EMIS) is larger, with a market capitalization of $162.02M compared with $161.88M for Satellos Bioscience (MSLE).
Are Emmis Acquisition and Satellos Bioscience in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.